Female Health Co  

(Public, NASDAQ:FHCO)   Watch this stock  
Find more results for FHCO
+0.02 (1.29%)
Real-time:   1:46PM EST
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.51 - 1.57
52 week 1.26 - 4.41
Open 1.55
Vol / Avg. 20,941.00/48,937.00
Mkt cap 44.57M
P/E 14.15
Div/yield     -
EPS 0.11
Shares 28.76M
Beta 1.08
Inst. own 22%
Dec 1, 2015
Q4 2015 Female Health Co Earnings Call - 11:15AM EST - Add to calendar
Dec 1, 2015
Q4 2015 Female Health Co Earnings Release - 9:30AM EST - Add to calendar
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin 14.99% 9.93%
Operating margin 18.61% 16.02%
EBITD margin - 18.43%
Return on average assets 12.86% 7.28%
Return on average equity 14.81% 8.18%
Employees 49 -
CDP Score - -


United States - Map
+1-312-5959123 (Phone)
+1-312-5959122 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


The Female Health Company, is a Female Condom company. The Company is engaged in manufacturing, marketing and selling FC2 Female Condom (FC2). FC2 is used for both disease prevention and family planning, the public health sector is the Company’s market. The Company operates in one industry segment which includes the development, manufacture and marketing of consumer health care products. The FC2 product offered by the Company facilitates dual protection for women against both unintended pregnancy and STIs, including HIV and AIDS, its market encompasses both family planning and disease prevention. FC2’s primary usages are for disease prevention and family planning, the public health sector is the Company’s main market. The Company markets products that prevent the transmission of HIV and AIDS through sexual intercourse: the male condom and FC2.

Officers and directors

Overton B. Parrish Jr. Chairman of the Board, Chief Executive Officer
Age: 81
Bio & Compensation  - Reuters
Michele Greco Chief Financial Officer, Executive Vice President, IR Contact Officer
Age: 56
Bio & Compensation  - Reuters
Susan Ostrowski Executive Vice President of Sales and Marketing
Age: 58
Bio & Compensation  - Reuters
Martin Clifford Tayler Executive Vice President - Global Operations
Age: 46
Bio & Compensation  - Reuters
Janet Lee Controller
Age: 50
Bio & Compensation  - Reuters
William R. Gargiulo Jr. Secretary, Director
Age: 86
Bio & Compensation  - Reuters
Donna Felch Director
Age: 67
Bio & Compensation  - Reuters
David R. Bethune Independent Director
Age: 74
Bio & Compensation  - Reuters
Mary Margaret Frank Ph.D. Independent Director
Age: 46
Bio & Compensation  - Reuters
Andrew S. Love Jr. Independent Director
Age: 71
Bio & Compensation  - Reuters